Prosecution Insights
Last updated: August 18, 2026

Examiner: MARTIN, RACHEL E

Tech Center 1700 • Art Units: 1651 1652 1657 1682 1792

This examiner grants 54% of resolved cases

Performance Statistics

53.6%
Allow Rate
-11.4% vs TC avg
109
Total Applications
+56.4%
Interview Lift
1179
Avg Prosecution Days
Based on 69 resolved cases, 2023–2026

Rejection Statute Breakdown

10.3%
§101 Eligibility
13.1%
§102 Novelty
38.3%
§103 Obviousness
33.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18847617 CARBAMOYL-PHOSPHATE SYNTHETASE LARGE SUBUNIT VARIANT AND L-ORNITHINE PRODUCTION METHOD USING SAME Non-Final OA CJ CHEILJEDANG CORPORATION
17742035 PRODUCTION METHOD FOR LIPID PARTICLES IN LIQUID AND METHOD FOR CULTURING MICROORGANISMS Final Rejection KANEKA CORPORATION
18688207 BIOCOMPATIBLE UNDERLAYS FOR LIVING EXTRACTION OF HYDROCARBONS FROM ENGINEERED MICROBES Non-Final OA King Abdullah University of Science and Technology
17570104 FUSION PROTEIN NANODISK COMPOSITIONS AND METHODS OF TREATMENT Non-Final OA The Brigham and Women's Hospital, Inc.
17769452 METHOD FOR EVALUATING DRUG TOXICITY Non-Final OA Takeda Pharmaceutical Company Limited
18719904 COMPOSITIONS AND METHODS INVOLVING PROTEASES SPECIFIC FOR MANNOSE-MODIFIED PROTEINS Non-Final OA DANISCO US INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month